• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.69 0.07(1.93%) Jan 27, 4:00PM EST
    Add to Portfolio
    Prev Close:3.62
    Open:3.57
    Bid:3.38 x 200
    Ask:N/A
    1y Target Est:8.83
    Beta:4.64
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:3.54 - 3.76
    52wk Range:3.25 - 9.57
    Volume:2,347,708
    Avg Vol (3m):2,819,860
    Market Cap:396.28M
    P/E (ttm):N/A
    EPS (ttm):-1.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback